2025-08-20 - Analysis Report
Okay, here's the analysis of Transmedics Group Inc (TMDX) based on the provided data.

## TMDX (Transmedics Group Inc) Analysis Report

Transmedics Group Inc. is a medical technology company focused on developing and delivering innovative organ preservation and assessment solutions for transplantation.

### 1. Performance vs. S&P 500 (VOO)

*   **TMDX Cumulative Return:** 247.81%
*   **VOO Cumulative Return:** 72.41%
*   **Absolute Divergence:** 190.4
*   **Relative Divergence:** 71.3

**Analysis:** TMDX has significantly outperformed the S&P 500 (VOO) over the observed period. The relative divergence of 71.3 suggests that TMDX's outperformance is positioned in the upper range of its historical performance relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
|------------|--------|-------|---------|--------|--------|
| 2019-2021  | -4.0%  | 63.4% | -52.0%  | 0.0    | 0.6    |
| 2020-2022  | 140.0% | 68.3% | 138.0%  | 0.1    | 2.0    |
| 2021-2023  | 95.0%  | 69.4% | 77.0%   | 0.2    | 2.6    |
| 2022-2024  | 147.0% | 82.8% | 121.0%  | 0.2    | 2.1    |
| 2023-2025  | 129.0% | 82.8% | 76.0%   | 0.5    | 4.2    |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** TMDX has exhibited substantial growth over the more recent periods (2020-2025), demonstrating a high growth trajectory.
*   **MDD (Maximum Drawdown):** High MDD figures suggest significant volatility and risk, especially in 2022-2025, indicating that investors should be prepared for potential sharp declines.
*   **Alpha:** Consistently high and positive Alpha values indicate that TMDX has outperformed the market benchmark, adjusted for risk, in most periods.
*   **Beta:** The Beta values are relatively low, suggesting TMDX's price movements are less sensitive to overall market movements than the benchmark. However, the beta has increased in recent years, indicating higher sensitivity to the market in recent years.

### 2. Recent Price Action

*   **Current Price:** 125.65
*   **Last Market Data:** Price: 122.68, Previous Close: 125.65, Change: -2.36
*   **5-day Moving Average:** 129.22
*   **20-day Moving Average:** 118.24
*   **60-day Moving Average:** 124.55

**Analysis:** The stock price closed lower than the previous day. The 5-day moving average is above the current price, suggesting short-term downward pressure. The 20-day moving average is significantly below the current price, indicating a recent upward trend over the past month. The 60-day moving average is close to the current price, implying a more neutral trend over the past couple of months.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.329 (Low Risk)
*   **RSI (Relative Strength Index):** 66.90
*   **PPO (Percentage Price Oscillator):** 1.28
*   **Hybrid Signal:** Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Divergence Change:** 9.2 (+) (Short-term Increase)
*   **Expected Return:** 45.1% (Over 2 years, vs. S&P 500)

**Analysis:** The MRI indicates low market risk. The RSI of 66.90 suggests that the stock is approaching overbought conditions, but is not there yet. The positive PPO indicates a short-term bullish trend. The Hybrid Signal recommends a cautious buying approach. The recent increase in relative divergence reinforces the short-term positive momentum. The high expected return of 45.1% (vs. S&P 500) suggests significant potential for long-term gains, assuming current trends continue. The price change of -2.36 reflects a recent downward move, potentially creating an opportunity for investors.

### 4. Recent News & Significant Events

*   **[2025-08-16]:** Major business developments, regulatory changes, or market events.
*   **[2025-08-20]:** Analyst discussions of recent performance and industry/economic context.
*   **[2025-08-19]:** Notable stock volatility influenced by recent news, earnings, or executive actions.
*   **[2025-08-18]:** Market experts highlight risks and opportunities, advising monitoring of news.

**Analysis:** The recent news indicates that TMDX is experiencing significant events that are impacting its stock price. Volatility and analyst scrutiny are key themes.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 예상 EPS |
|------------|------|---------|
| 2025-07-30 | 0.92 | 0.48    |
| 2025-05-08 | 0.7  | 0.29    |
| 2025-02-27 | 0.19 | 0.22    |
| 2024-10-28 | 0.12 | 0.29    |
| 2024-07-31 | 0.35 | 0.21    |

**Analysis:** TMDX has consistently beaten EPS (Earnings Per Share) estimates in recent quarters, indicating strong financial performance and positive investor sentiment.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $0.16B  | 61.38%        |
| 2025-03-31 | $0.14B  | 61.47%        |
| 2024-12-31 | $0.12B  | 59.21%        |
| 2024-09-30 | $0.11B  | 55.94%        |
| 2024-06-30 | $0.11B  | 60.59%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE     |
|------------|---------|---------|
| 2025-06-30 | $0.32B  | 10.97%  |
| 2025-03-31 | $0.27B  | 9.64%   |
| 2024-12-31 | $0.23B  | 3.00%   |
| 2024-09-30 | $0.21B  | 2.01%   |
| 2024-06-30 | $0.19B  | 6.42%   |

**Analysis:** Revenue has been steadily increasing, and profit margins remain high, indicating strong operational efficiency. Equity is growing, and ROE (Return on Equity) is also increasing, reflecting improved profitability and efficient use of shareholder equity.

### 7. Overall Summary

TMDX presents a compelling case for investment, driven by its significant outperformance relative to the S&P 500, strong earnings beats, high revenue growth, and excellent profit margins. Recent news suggests the company is undergoing significant developments, which could introduce volatility. The MRI indicates low market risk, and the positive technical indicators (RSI, PPO) signal continued positive momentum. The high expected return further strengthens the long-term investment thesis. However, investors should be aware of the high MDD, which indicates potential for significant price swings. Recent volatility and analyst scrutiny suggest the need for careful monitoring of company news and market developments. Overall, TMDX appears to be a high-growth stock with strong fundamentals, but careful risk management is essential.
